FEBS Letters
Volume 583, Issue 8 , Pages 1331-1336, 17 April 2009

The effect of 2-deoxy-d-glucose on Werner syndrome RecQ helicase gene

Edited by Vladimir Skulachev

  • Bei Zhou

      Affiliations

    • Department of Gene Regulation, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
  • ,
  • Takashi Ikejima

      Affiliations

    • China–Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang 110016, China
  • ,
  • Takeshi Watanabe

      Affiliations

    • Department of Gene Regulation, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
  • ,
  • Keiko Iwakoshi

      Affiliations

    • Department of Gene Regulation, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
  • ,
  • Yohei Idei

      Affiliations

    • Department of Gene Regulation, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
  • ,
  • Sei-ichi Tanuma

      Affiliations

    • Department of Biochemistry and Molecular Biology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
    • Department of Genome and Drug Research Center, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
  • ,
  • Fumiaki Uchiumi

      Affiliations

    • Department of Gene Regulation, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
    • Corresponding Author InformationCorresponding author. Fax: +81 4 7121 3608.

Received 17 December 2008; received in revised form 16 March 2009; accepted 17 March 2009. published online 23 March 2009.

Abstract 

Caloric restriction (CR) is known to effectively elongate mammalian life-spans. The compound 2-deoxy-d-glucose (2DG), which is often used as an inhibitor of glucose utilization, is a mimetic agent of CR. In this study, we examined the changes of telomerase and Werner’s syndrome RecQ (WRN) helicase after treatment with 2DG, because of the involvement of recQ helicase in the regulation of telomeres. Interestingly, 2DG treatment increased the expression of WRN protein in accordance with induction of its promoter activity and gene expression. Furthermore, the activation of telomerase was observed after 2DG treatment, whereas it resulted in the reduction of cell proliferation. These results suggest that 2DG could up-regulate telomere maintenance factors accompanied with suppression of proliferation.

Abbreviations: BS, Bloom’s syndrome, CR, caloric restriction, 2DG, 2-deoxy-d-glucose, Luc, luciferase, MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, RT-PCR, reverse transcriptase polymerase chain reaction, TERT, telomerase reverse transcriptase, TRAP, telomerase amplification protocol, WS, Werner’s syndrome

Keywords: BLM, 2DG, HELB, p21, RecQ helicase, Sp1, Telomerase, TERT, WRN

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(09)00223-3

doi:10.1016/j.febslet.2009.03.033

FEBS Letters
Volume 583, Issue 8 , Pages 1331-1336, 17 April 2009